New radiation approach aims to ease head and neck cancer pain in fewer sessions

NCT ID NCT05674396

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This phase 2 trial tests whether a modern radiation technique called stereotactic body radiotherapy (SBRT) can safely deliver a strong dose of radiation in just 3 to 5 sessions to relieve symptoms from head and neck cancer. The study involves 108 adults whose cancer cannot be cured. Researchers will compare symptom changes using a standard questionnaire to see if the shorter course works better than traditional palliative radiation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
stereotactic body radiation therapy (SBRT)
What this could lead to
If successful, this could offer a quicker, more effective way to reduce pain and other symptoms from head and neck cancer that cannot be cured.
What could go wrong
This is a small, early-phase trial (108 participants) testing a new radiation schedule. It may not prove better than standard palliative radiation, and stronger doses could increase side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.